142 related articles for article (PubMed ID: 17549498)
1. Reticulated platelet levels in patients with ulcerative colitis.
Kayahan H; Akarsu M; Ozcan MA; Demir S; Ates H; Unsal B; Akpinar H
Int J Colorectal Dis; 2007 Dec; 22(12):1429-35. PubMed ID: 17549498
[TBL] [Abstract][Full Text] [Related]
2. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume.
Yüksel O; Helvaci K; Başar O; Köklü S; Caner S; Helvaci N; Abayli E; Altiparmak E
Platelets; 2009 Jun; 20(4):277-81. PubMed ID: 19459134
[TBL] [Abstract][Full Text] [Related]
3. Red cell distribution width for assessment of activity of inflammatory bowel disease.
Cakal B; Akoz AG; Ustundag Y; Yalinkilic M; Ulker A; Ankarali H
Dig Dis Sci; 2009 Apr; 54(4):842-7. PubMed ID: 18716874
[TBL] [Abstract][Full Text] [Related]
4. The relationship between the neutrophil-lymphocyte ratio and disease activity in patients with ulcerative colitis.
Demir AK; Demirtas A; Kaya SU; Tastan I; Butun I; Sagcan M; Sahin S; Tasliyurt T; Yilmaz A
Kaohsiung J Med Sci; 2015 Nov; 31(11):585-90. PubMed ID: 26678939
[TBL] [Abstract][Full Text] [Related]
5. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
Kapsoritakis AN; Koukourakis MI; Sfiridaki A; Potamianos SP; Kosmadaki MG; Koutroubakis IE; Kouroumalis EA
Am J Gastroenterol; 2001 Mar; 96(3):776-81. PubMed ID: 11280550
[TBL] [Abstract][Full Text] [Related]
6. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity.
Torun S; Tunc BD; Suvak B; Yildiz H; Tas A; Sayilir A; Ozderin YO; Beyazit Y; Kayacetin E
Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):491-7. PubMed ID: 22841412
[TBL] [Abstract][Full Text] [Related]
7. Could platelet indices be new biomarkers for inflammatory bowel diseases?
Öztürk ZA; Dag MS; Kuyumcu ME; Cam H; Yesil Y; Yilmaz N; Aydinli M; Kadayifci A; Kepekci Y
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):334-41. PubMed ID: 23426536
[TBL] [Abstract][Full Text] [Related]
8. Elevated thrombopoietin serum levels in patients with inflammatory bowel disease.
Kapsoritakis AN; Potamianos SP; Sfiridaki AI; Koukourakis MI; Koutroubakis IE; Roussomoustakaki MI; Manousos ON; Kouroumalis EA
Am J Gastroenterol; 2000 Dec; 95(12):3478-81. PubMed ID: 11151880
[TBL] [Abstract][Full Text] [Related]
9. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study.
Pamuk GE; Vural O; Turgut B; Demir M; Umit H; Tezel A
Am J Hematol; 2006 Oct; 81(10):753-9. PubMed ID: 16941615
[TBL] [Abstract][Full Text] [Related]
10. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
Mawdsley JE; Macey MG; Feakins RM; Langmead L; Rampton DS
Gastroenterology; 2006 Aug; 131(2):410-9. PubMed ID: 16890594
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of blood platelets and mean platelet volume in patients with ulcerative colitis.
Chen Z; Lu Y; Wu J; Zhang H
J Int Med Res; 2021 Apr; 49(4):3000605211009715. PubMed ID: 33884913
[TBL] [Abstract][Full Text] [Related]
12. Inverse Association Between Circulating Monocyte-Platelet Complexes and Inflammation in Ulcerative Colitis Patients.
Zamora C; Canto E; Nieto JC; Garcia-Planella E; Gordillo J; Ortiz MA; Suarez-Calvet X; Perea L; Julia G; Juarez C; Vidal S
Inflamm Bowel Dis; 2018 Mar; 24(4):818-828. PubMed ID: 29529212
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical activity of Prohibitin-2 and Stomatin-Like Protein-2 in patients with ulcerative colitis.
Küçük İ; Tanoğlu A; Öncü K; Yılmaz İ; Kara M; Beyazıt Y; Akyol T; Kaplan M; Özarı HO; Yazgan Y
Turk J Gastroenterol; 2016 May; 27(3):233-8. PubMed ID: 27124283
[TBL] [Abstract][Full Text] [Related]
14. Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis?
Posul E; Yilmaz B; Aktas G; Kurt M
Wien Klin Wochenschr; 2015 Apr; 127(7-8):262-5. PubMed ID: 25576331
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of circulating midkine in ulcerative colitis.
Krzystek-Korpacka M; Neubauer K; Matusiewicz M
Clin Chem Lab Med; 2009; 47(9):1085-90. PubMed ID: 19728850
[TBL] [Abstract][Full Text] [Related]
16. Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease: A pilot study.
Ye L; Zhang YP; Yu N; Jia YX; Wan SJ; Wang FY
Medicine (Baltimore); 2017 Mar; 96(11):e6323. PubMed ID: 28296751
[TBL] [Abstract][Full Text] [Related]
17. [Comparative usefulness of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of ulcerative colitis].
Ha JS; Lee JS; Kim HJ; Moon TG; Chang DK; Lee JH; Kim YH; Rhee PL; Kim JJ; Rhee JC
Korean J Gastroenterol; 2006 Nov; 48(5):313-20. PubMed ID: 17132919
[TBL] [Abstract][Full Text] [Related]
18. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis.
Osada T; Ohkusa T; Okayasu I; Yoshida T; Hirai S; Beppu K; Shibuya T; Sakamoto N; Kobayashi O; Nagahara A; Terai T; Watanabe S
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S262-7. PubMed ID: 19120909
[TBL] [Abstract][Full Text] [Related]
19. Serum adenosine deaminase activity as a predictor of disease severity in ulcerative colitis.
Beyazit Y; Koklu S; Tas A; Purnak T; Sayilir A; Kurt M; Turhan T; Celik T; Suvak B; Torun S; Akbal E
J Crohns Colitis; 2012 Feb; 6(1):102-7. PubMed ID: 22261534
[TBL] [Abstract][Full Text] [Related]
20. The role of mean platelet volume in patients with Takayasu arteritis.
Peng YF; Guo J; Deng YB
Ann Clin Biochem; 2017 Mar; 54(2):273-278. PubMed ID: 27329216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
